Search companies or stocks...
Live valuation snapshot for Astria Therapeutics, Inc. (ATXS) is loading. Our DCF, P/E, and P/S fair value models update this section when data is ready.
Current Price: $12.58
Valuation: —
Confidence: —
How we calculate fair value: We combine DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models to estimate intrinsic value. This figure is for information only - not investment advice - and assumptions may not reflect actual market conditions. We encourage doing your own research or speaking with a financial advisor before making investment decisions.
Search our company database (same as the site header), pick a match, or type a ticker to open its intrinsic value analysis.
Is Astria Therapeutics, Inc. (ATXS) undervalued or overvalued? Our DCF, P/E Multiple, and P/S Multiple fair value models will publish a live verdict here when valuation data is available for this symbol.
Astria Therapeutics, Inc. (ATXS) fair value vs market price uses DCF, P/E Multiple, and P/S Multiple models to estimate intrinsic value against the live quote. Valuation comparison data will appear here when available for this symbol.
Our models calculate the intrinsic value of Astria Therapeutics, Inc. (ATXS) using DCF, P/E Multiple, and P/S Multiple approaches based on projected cash flows, growth rate, and discount rate. Sign in to Tickerplace Pro to view the full dollar estimate.
Our valuation model compares ATXS's current market price against its calculated intrinsic value to determine if the stock is undervalued or overvalued. See the full analysis on this page.
Tickerplace calculates ATXS's intrinsic value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We project future cash flows, apply a discount rate that reflects investment risk, and compare the resulting fair value estimate to the current market price.
Peers for ATXS: open their intrinsic value pages.
